Back close

Paraptosis: a non-apoptotic cell death pathway to target cancer

School: School of Biotechnology

Paraptosis: a non-apoptotic cell death pathway to target cancer

Many cancer cells develop resistance to the apoptotic signals and flourish in the system. We are trying to target these defiant cells by inducing an alternative cell death pathway through natural products. One of the non-apoptotic mode of programmed cell death known as “paraptosis” or cytoplasmic vacuolation mediated cell death is one of our areas of interest.

We screen a large number of natural products and synthetic derivatives for anti-cancer activity in collaboration with Professor Asoke Banerji of School of Biotechnology and try to understand their mode of action with respect to cell death. Along with screening for anticancer compounds, we filter natural products that cause parasitic death. We are using C. elegans as an in vivo model system to study anti-parasitic and anti-cancer death mechanism in collaboration with Dr. Sanjay Pal.

Related Projects

To strenthen the Post Graduate Teaching and Research Facilities in the department on 50:50 mode being a Private Academic Institution
To strenthen the Post Graduate Teaching and Research Facilities in the department on 50:50 mode being a Private Academic Institution
Development of New Tools to Reverse Antibiotic Resistance in Pathogens Like Pseudomonas Aeruginosa
Development of New Tools to Reverse Antibiotic Resistance in Pathogens Like Pseudomonas Aeruginosa
Label – Free Quantitative Proteomics Analysis to Study the Effect of Triclosan on Delta-Haemolysin: A Haemolytic Factor of Methicillin – Resistant Staphylococcus Aureus
Label – Free Quantitative Proteomics Analysis to Study the Effect of Triclosan on Delta-Haemolysin: A Haemolytic Factor of Methicillin – Resistant Staphylococcus Aureus
Matrix Binding microbes and bacteriophages to counter infection
Matrix Binding microbes and bacteriophages to counter infection
Development of Host-directed Therapies for Drug Resistant Klebsiella Pneumonia Infections
Development of Host-directed Therapies for Drug Resistant Klebsiella Pneumonia Infections
Admissions Apply Now